An integrative bioinformatics approach for identifying subtypes and subtype-specific drivers in cancer

2012 IEEE Symposium on Computational Intelligence and Computational Biology, CIBCB 2012

Volumn , Issue , 2012, Pages 169-176

  Chen, Peikai ^a   Hung, Y S ^a   Fan, Yubo ^b   Wong, Stephen T C ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEX DISEASE; COPY NUMBER; POINT MUTATIONS;

ARTIFICIAL INTELLIGENCE; DISEASES;

BIOINFORMATICS;

EID: 84864033158     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/CIBCB.2012.6217227     Document Type: Conference Paper

References (22)

1. C. M. Perou, T. Sorlie et al., "Molecular portraits of human breast tumours," Nature, vol. 406, no. 6797, pp. 747-52, 2000.
2. R. G. Verhaak, K. A. Hoadley et al., "Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in pdgfra, idh1, egfr, and nf1," Cancer Cell, vol. 17, no. 1, pp. 98-110, 2010.
3. M. Kool, J. Koster et al., "Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features," PLoS One, vol. 3, no. 8, p. e3088, 2008.
4. J. E. Visvader, "Cells of origin in cancer," Nature, vol. 469, no. 7330, pp. 314-322, 2011.
5. T. R. Golub, D. K. Slonim et al., "Molecular classification of cancer: class discovery and class prediction by gene expression monitoring," Science, vol. 286, no. 5439, pp. 531-7, 1999.
6. E. Bair and R. Tibshirani, "Semi-supervised methods to predict patient survival from gene expression data." PLoS Biol, vol. 2, no. 4, p. E108, Apr 2004.
7. Y. Gao and G. Church, "Improving molecular cancer class discovery through sparse non-negative matrix factorization," Bioinformatics, vol. 21, no. 21, pp. 3970-5, 2005.
8. M. R. Stratton, P. J. Campbell, and P. A. Futreal, "The cancer genome," Nature, vol. 458, no. 7239, pp. 719-24, 2009.
9. Y. Cho, P. Tamayo et al., "Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome," J Clin Oncol., vol. 12, no. 6, pp. 1424-1430, 2010.
10. P. A. Northcott, A. Korshunov et al., "Medulloblastoma comprises four distinct diseases," Journal of Clinical Oncology, vol. 12, no. 6, pp. 1408-1414, 2010.
11. A. Y. Ng, M. I. Jordan, and Y. Weiss, "On spectral clustering: Analysis and an algorithm," in Advances In Neural Information Processing Systems. MIT Press, 2001, pp. 849-856.
12. R. Tibshirani, G. Walther, and T. Hastie, "Estimating the number of clusters in a data set via the gap statistic," J. R. Stat. Soc. Ser. BMethodological, vol. 63, pp. 411-423, 2001.
13. M. G. Schimek, Smoothing and regression: approaches, computation, and application, ser. Wiley series in probability and statistics Applied probability and statistics section. New York: Wiley, 2000.
14. P. Gibson, Y. Tong et al., "Subtypes of medulloblastoma have distinct developmental origins," Nature, vol. 468, no. 7327, pp. 1095-9, 2010.
15. A. S. Hadi, "Identifying multiple outliers in multivariate data," Journal of the Royal Statistical Society. Series B (Methodological), vol. 54, no. 3, pp. pp. 761-771, 1992.
16. S. Monti, P. Tamayo et al., "Consensus clustering: A resamplingbased method for class discovery and visualization of gene expression microarray data," Machine Learning, vol. 52, no. 1-2, pp. 91-118, 2003.
17. Y. Freund and R. E. Schapire, "Experiments with a New Boosting Algorithm," in International Conference on Machine Learning, 1996, pp. 148-156.
18. M. Culp, K. Johnson, and G. Michailidis, "ada: an r package for stochastic boostong," Journal of Statistical Software, vol. 17, no. 2, pp. pp. 1-27, October 2006.
19. B. Niu, Y.-D. Cai et al., "Predicting protein structural class with adaboost learner." Protein Pept Lett, vol. 13, no. 5, pp. 489-492, 2006.
20. V. G. Tusher, R. Tibshirani, and G. Chu, "Significance analysis of microarrays applied to the ionizing radiation response," Proc Natl Acad Sci U S A, vol. 98, no. 9, pp. 5116-21, 2001.
21. R. Beroukhim, G. Getz et al., "Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma," Proc. Nat. Acad. of Sci., vol. 104, no. 50, pp. 20 007-20 012, 2007.
22. M. D. Bacolod, S. M. Lin et al., "The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide." Curr Cancer Drug Targets, vol. 8, no. 3, pp. 172-179, May 2008.